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Abstract
Introduction. Prostatic gland basal cell proliferations ex-
hibit morphological continuum ranging from basal cell hy-
perplasia to basal cell carcinoma. In the following report, we
described clinical features, morphological spectrum, neuro-
endocrine differentiation and histogenesis of prostatic gland
basal cell carcinoma in our patient. Case report. Hema-
toxylin-eosin (HE), Alcian blu-periodic acid schiff (AB-
PAS) at pH 2.5 stained sections and the avidin-biotin-
peroxidase complex (ABC), were performed on prostate
gland paraffin-embedded tissue. Monoclonal antibodies di-
rected against cytokeratin (34βE12) which selectively stains
basal cells, prostate specific antigen (PSA), chromogranine
A, neuron-specific enolase (NSE), synaptophysin and
CD56, were used. Basal cell proliferations exhibited a mor-
phological continuum ranging from basal cell hyperplasia to
prostatic gland carcinoma. In these prostatic lesions, posi-
tive reactivity was demonstrated for 34βE12 and CD56.
These findings indicate that the basaloid cells of basal cell
hyperplasia, florid basal cell hyperplasia, atypical basal cell
hyperplasia and basal cell carcinoma are derived from basal
cells of the normal prostate gland suggesting a continuum in
the progression of hyperplasia to benign and then malignant
neoplasia. The presence of CD56 protein in the discovered
lesions may be related to their neuroendocrine differentia-
tion. Conclusion. The fact, that our patient was well six
years after the radical prostatectomy supports the belief of
some authors that basal cell carcinoma represents a low
grade carcinoma with an excellent prognosis.
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Apstrakt
Uvod.  Proliferacija bazalnih ćelija žlezda prostate poka-
zuje morfološki kontinuum od hiperplazije do karcinoma
bazalnih ćelija. Prikazali smo kliničke odlike, morfološki
spektar, bazalnoćelijsku proliferaciju, neuroendokrinu dife-
rencijaciju i histogenezu karcinoma bazalnih ćelija žlezda
prostate.  Prikaz bolesnika. Preseci parafinskih blokova
tkiva prostate bojeni su metodom hematoksilin/eozin
(HE), alcian blue (AB) – Periodic acid Schiff (PAS) pri pH 2,5 i
avian-biotin complex (ABC). Upotrebljena su monoklonska
antitela usmerena prema citokeratinu (34βE12) koja selek-
tivno boje bazalne ćelije, prostata specifični antigen (PSA),
hromogranin A, neuron-specifična enolaza (NSE), sinap-
tofizin i CD56. Proliferacija bazalnih ćelija pokazala je
morfološki kontinuum od hiperplazije bazalnih ćelija do
karcinoma prostate. U identifikovanim lezijama prostate
prikazana je pozitivna reakcija za 34βE12 i CD56. Ovi na-
lazi ukazuju na to da bazaloidne ćelije u hiperplaziji, flori-
dnoj hiperplaziji bazalnih ćelija, atipičnoj hiperplaziji ba-
zalnih ćelija i karcinomu bazalnih ćelija nastaju iz bazalnih
ćelija normalnih žlezda prostate ukazujući na kontinuum u
progresiji hiperplazije ka benignim i malignim neoplaz-
mama. Prisustvo CD56 proteina u otkrivenim lezijama
može biti posledica njihove neuroendokrine diferencijaci-
je. Zaključak. Činjenica da je prikazani bolesnik u dob-
rom stanju šest godina posle radikalne prostatektomije u
saglasnosti je sa mišljenjem nekih autora da karcinom ba-
zalnih ćelija prostate predstavlja malignu neoplazmu nis-
kog gradusa malignosti sa odličnom prognozom.
Ključne reči:
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Introduction
Prostatic basal cell carcinoma is an uncommon neoplasm
accounting for less than 0.01% of all prostatic gland carcinomas,
composed of prostatic basal cells 
1–14. In addition, the gross pat-
terns have been reported for fewer than 10 cases 
15. It is believed
that a subset of basal cells are prostatic epithelial stem cells,
which can give rise to a spectrum of proliferative lesions ranging
from basal cell hyperplasia (BCH) to basal cell carcinoma
(BCC) 
1–4. The distinction between these forms of BCH (in-
cluding the variant with florid BCH) and BCC depends on mor-
phological, immunohistochemical criteria and on the degree of
cell proliferation 
2–8. Prostatic BCC is caracterised by prolifera-
tion of cells arranged in various architectural patterns. Two
morphological variants of BCC can be recognised in the prostate
8, 9. Islands and cords of epithelial cells with peripheral palisad-
ing characterise the first type, morphologically similar to BCC
of the skin. The second type, also called adenoid cystic carci-
noma, is composed of nests of infiltrating tumor cells with an
adenoid cystic pattern, morphologically similar to adenoid cystic
carcinoma of the salivary glands 
8, 9. Neuroendocrine differen-
tiation has been reported only in typical and small cell prostatic
carcinoma. It takes several forms. Pure neuroendocrine carci-
noma is rare and includes carcinoid tumor 
10–13. Immunohisto-
chemistry clearly indicates that basal cell proliferations have the
same immunophenotype as the basal cells present in normal
ducts and acini. The cells are positively and strongly stained for
high-molecular weight cytokeratin (34βE12) and p63, consoli-
dated markers for basal cells in the prostate 
4, 7. We reported a
case with prostatic BCC, pointing out its neuroendocrine differ-
entiation and an excellent prognosis.
Case report
A 58-year-old man presented in April 2001 with a 16-
month history of increasing urinary obstructive symptoms.
Diffuse enlargement of the prostate was documented by
transrectal ultrasound and digital rectal examination. The
preoperative total serum prostate-specific antigen (PSA) con-
centration was 2.5 μg/mL. The patient had radical prostatec-
tomy. After diagnosing basal cell carcinoma of the prostate, a
metastatic workup for tumor had normal results. The patient
was alive without evidence of disease six years after the pros-
tatectomy. Twelve blocks of prostate from a prostatectomy
specimen were examined. Formalin-fixed, paraffin-embedded
sections, 5 μm in thickness, were clasically processed and
stained with hematoxylin-eosin (HE) slides, also were stained
with Alcian blu (AB) –periodic acid schiff (PAS) at pH 2.5.
For immunoperoxidase studies on the formalin fixed, paraffin
wax embedded tissues, antibodies to the following antigens
were used: 34βE12 to highlight the basal cells (Dako Cytoma-
tion), rabbit anti PSA to mark prostatic secretory cells and,
rabbit anti-chromogranin A, synaptophysin, and CD56 (to dis-
cover neuroendocrine differentiation of the prostatic gland
BCPs). Selected sections of the prostate were stained by
means of the labeled streptavidin – biotin method (Dako Cy-
tomation; 1 : 100). The immunohistochemical staining of cells
was recorded as either positive or negative one. At least 500
cells were counted on each slide.
Gross and microscopical pathology
The surgical specimen weighted 120 g and measured 4
× 3.5 cm. The cut surface was white and nodular. At one end
of the specimen an ovoid area was identified. The paren-
chyma was otherwise gray-white with occasional small cysts
(Figure 1a). The surrounding prostate tissue was grossly and
histologically unremarkable.
Microscopically, basal cell proliferations (BCPs) ex-
hibit a morphological continuum ranging from ordinary BCH
to prostatic gland BCC (Figures 1b–2d). The nests were
composed of small, ovoid, basaloid cells having scanty cyto-
plasm and uniform nuclei with finely dispersed chromatin.
Nucleoli were absent (Figures 1b and 1c). These cells stained
Fig. 1: A – macroscopic pattern; B – origin of solid nest from normal basal cells (immunostain for 34βE12, ×300);
C – BCH (solid clusters of basaloid cells, HE ×200); D – immunostain for 34βE12 cytokeratin demonstrating strong
positive reactivity (ABC ×200).
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positively for 34βE12 and negatively for PSA (Figures 1d,
2a). Neuroendocrine markers-chromogranin, neuron-specific
enolase (NSE) and sinaptophysin could not mark neuroendo-
crine cells. The only marker that was able to detect these
cells was CD56 (Figure 2b). The basal cells of the florid
BCH contained minimal cytoplasm, moderate nuclear pleo-
morphism, prominent nucleoli and mitosis. The prostatic
gland BCC was characterized by infiltrative growth and large
irregular nests punctuated by cribriform spaces filled with
small globules of dense eosinophilic material surrounded by
basal cells. This material was AB-positive mucin in some ar-
eas and intensive PAS-positive hyaline material in others;
peripheral palisading pattern also was evident, as well as
myxoid stroma (Figure 2c). Some dense cords and islands of
basaloid cells showed a significant nuclear hyperchromasia
and higher mitotic activity (Figure 2d).
Discussion
Prostatic gland BCH is an uncommon proliferative le-
sion whose major importance is possible confusion with pro-
static intraepitelial neoplasia (PIN) and poorly differentiated
(mostly Glison’s 5) adenocarcinoma 
2, 9, 13. The distinction
between these two carcinomas depends on the following
morphological and immunohistochemical features: small
nests of basaloid cells have scanty cytoplasm, uniform nu-
clei, finely dispersed chromatin and occasional small nucle-
oli, with multilayered positively staining of the basal cells for
34βE12 and, negatively for PSA 
12–14. The distinction of
BCC from florid/atypical BCH is also very important, in-
cluding extensive infiltration between normal prostatic
gland, extension out of the prostate gland, perineural inva-
sion or necrosis, as well as rare distant metastasis 
2–11.
Prostatic neuroendocrine cells most likely derive from
local stem cells and represent terminal differentiation in
benign prostate tissue. A frequent occurrence of neuroen-
docrine (NE) differentiation in prostatic adenocarcinoma
(author’s expirience) obviously reflects the differentiation
repertoire of its stem cells 
12, 13. Pure neuroendocrine differ-
entiation is rare and includes carcinoid tumor 
12. However,
to the best of the authors knowledge, the neuroendocrine
differentiation has not been described in prostatic BCC, by
using chromogranin, neron-specific enolase and synapto-
physin, that we also have confirmed. But, by using CD56
(neural cell adhesion molecule), neuroendocrine marker for
both lung and prostatic small cell carcinomas and natural
killer cells 
14, we found a strong expression of CD56 inside
BCHs.
Conclusion
Prostatic gland basal cell proliferations range from or-
dinary BCH, to florid BCH and to BCC. Diagnosis of these
lesions depends on morphological and immunohistochemical
criteria. CD56 is an excellent marker for detection of neuro-
endocrine differentiation of BCHs.
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